Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Atorvastatin therapy in COVID-19 adult inpatients: A double-blind, randomized controlled trial
Lotfollah Davoodi, Hamed Jafarpour, Ziaeddin Oladi, et al.
IJC Heart & Vasculature (2021) Vol. 36, pp. 100875-100875
Open Access | Times Cited: 25

Showing 25 citing articles:

Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial
Parham Sadeghipour, Behnood Bikdeli, Azita H. Talasaz, et al.
BMJ (2022), pp. e068407-e068407
Open Access | Times Cited: 65
Survival of the hospitalized patients with COVID‐19 receiving atorvastatin: A randomized clinical trial
Majid Ghafoori, Hassan Saadati, Mohammadreza Taghavi, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 7, pp. 3160-3168
Open Access | Times Cited: 27
Statins in hospitalized COVID‐19 patients: A systematic review and meta‐analysis of randomized controlled trials
Yajuan Ren, Guizuo Wang, Dong Han
Journal of Medical Virology (2023) Vol. 95, Iss. 6
Closed Access | Times Cited: 15
A Dual Pharmacological Strategy against COVID-19: The Therapeutic Potential of Metformin and Atorvastatin
Luis Adrián De Jesús‐González, Rosa M. del Ángel, Selvin Noé Palacios-Rápalo, et al.
Microorganisms (2024) Vol. 12, Iss. 2, pp. 383-383
Open Access | Times Cited: 5
Atorvastatin Attenuated the Inflammatory Outcomes of COVID-19: A Double-Blind, Randomized Controlled Trial
Hajar Shokri‐Afra, Sudabe Baghery moghadam, Ziaeddin Oladi, et al.
Journal of Reports in Pharmaceutical Sciences (2025) Vol. 13, Iss. 1
Open Access
Adjunctive Statin Therapy in Patients with Covid-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Cynthia Florêncio de Mesquita, André Rivera, Beatriz Araújo, et al.
The American Journal of Medicine (2024) Vol. 137, Iss. 10, pp. 966-973.e11
Closed Access | Times Cited: 4
Atorvastatin for reduction of 28-day mortality in severe and critical COVID-19 patients: a randomized controlled trial
Naglaa Hamdi Eltahan, Neamat Hamdy Elsawy, Kholoud M. Abdelaaty, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 3
Effects of statin therapy in hospitalized adult COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials
Débora Pinheiro Xavier, Gabriel Cavalcante Lima, Lorena Gisele Ferreira Gomes, et al.
Einstein (São Paulo) (2023) Vol. 21
Open Access | Times Cited: 9
The Effects of Statins on Respiratory Symptoms and Pulmonary Fibrosis in COVID-19 Patients with Diabetes Mellitus: A Longitudinal Multicenter Study
Mohammadamin Sadeghdoust, Farnaz Aligolighasemabadi, Tania Dehesh, et al.
Archivum Immunologiae et Therapiae Experimentalis (2023) Vol. 71, Iss. 1
Open Access | Times Cited: 6
Prior Statin vs In-Hospital Statin Usage in Severe COVID-19: Review and Meta-Analysis
Iad Alhallak, Hakan Paydak, Jawahar L. Mehta
Current Problems in Cardiology (2023) Vol. 48, Iss. 9, pp. 101810-101810
Open Access | Times Cited: 6
Statin Use in Relation to COVID-19 and Other Respiratory Infections: Muscle and Other Considerations
Beatrice A. Golomb, Junhee Han, Peter H. Langsjoen, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 14, pp. 4659-4659
Open Access | Times Cited: 6
Cardiovascular drugs and COVID‐19 clinical outcomes: a systematic review and meta‐analysis of randomized controlled trials
Innocent G. Asiimwe, Sudeep Pushpakom, Richard M. Turner, et al.
British Journal of Clinical Pharmacology (2022) Vol. 88, Iss. 8, pp. 3577-3599
Open Access | Times Cited: 10
Adjunctive therapy with lipid-lowering agents in COVID-19: a systematic review and meta-analysis of randomized controlled trials
Amirmohammad Khalaji, Amir Hossein Behnoush, Sanam Alilou, et al.
Lipids in Health and Disease (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Association of early statin initiation during COVID-19 admission with inpatient mortality at an academic health system in Illinois, March 2020 to September 2022: a target trial emulation using observational data
Adovich S. Rivera, Omar Al-Heeti, Matthew J. Feinstein, et al.
BMJ Open (2024) Vol. 14, Iss. 10, pp. e085547-e085547
Open Access | Times Cited: 1
Treating COVID-19: Targeting the Host Response, Not the Virus
David S. Fedson
Life (2023) Vol. 13, Iss. 3, pp. 712-712
Open Access | Times Cited: 4
Effects of statins on clinical outcomes in hospitalized patients with COVID-19
Paulo Ricardo Martins‐Filho, José Augusto Soares Barreto-Filho, Antônio Carlos Sobral Sousa
European Journal of Internal Medicine (2022) Vol. 104, pp. 113-115
Open Access | Times Cited: 5
The Effectiveness of Mini‐Pulse Methylprednisolone in the Treatment of Patients With COVID‐19 in the Intensive Care Unit
Yousef Mohammadi‐kebar, Shahram Habibzadeh, Saeid Hoseininia, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 11
Open Access
Attitudes and Knowledge of Infertile Iranian Couples Among Treatment with Assisted Reproductive Technologies During COVID-19 Pandemics
Sepideh Peivandi, Alireza Razavi, Shervin Shafiei, et al.
Journal of Family & Reproductive Health (2022)
Open Access | Times Cited: 3
Senility and COVID-19 as two possible risk factors for loss of consciousness: A rare case report
Hamed Jafarpour, Roya Ghasemian, Maedeh Raei, et al.
Annals of Medicine and Surgery (2022) Vol. 80
Open Access | Times Cited: 2
Atorvastatin for Reduction of 28-day Mortality in Sever and Critical COVID-19 Patients: A Randomized Controlled Trial
Naglaa Hamdi Eltahan, Neamat Hamdy Elsawy, Kholoud M. Abdelaaty, et al.
Research Square (Research Square) (2023)
Closed Access
Role of Statin and Clinical Outcomes in COVID-19 Patients: A Protocol for Systematic Review and Meta-analysis of Randomized Controlled Trials
Amit Kumar, Sharmili Sinha, Jay Prakash, et al.
(2023) Vol. 2, Iss. 1, pp. 38-41
Open Access
Statins: Beneficial Effects in Treatment of COVID-19
Naser‐Aldin Lashgari, Nazanin Momeni Roudsari, Hedieh Sadat Shamsnia, et al.
Advances in experimental medicine and biology (2023), pp. 457-476
Closed Access
Statins and COVID-19: emerging evidence on the safety and efficacy of statins in COVID-19
Shweta Kapur, Prateek Lohia
Annals of Palliative Medicine (2022) Vol. 11, Iss. 4, pp. 1157-1159
Open Access
Effects of Statins on Clinical Outcomes in Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Paulo Ricardo Martins‐Filho, José Augusto Soares Barreto-Filho, Antônio Carlos Sobral Sousa
SSRN Electronic Journal (2022)
Closed Access
Phenotypical and Functional Alteration of γδ T Lymphocytes in COVID-19 Patients: Reversal by Statins
Marta Di Simone, Anna Maria Corsale, Elena Lo Presti, et al.
Cells (2022) Vol. 11, Iss. 21, pp. 3449-3449
Open Access
Page 1

Scroll to top